Search Within

Sujata Malhotra

Formats
  1. Meeting Abstract (5)
  2. Journal Article (1)
Groups
  1. Center for Hematologic Malignancies (4)
  2. Department of Medicine (4)
  3. Hematologic Malignancies, Division of (4)
  4. Lymphoma (4)
  5. Radiation Oncology, Department of (4)
  6. Survivorship Research (4)

More Groups

People
  1. Andrew Zelenetz (4)
  2. Craig Moskowitz (4)
  3. Joachim Yahalom (4)
  4. Stephen Nimer (4)
  5. Sandeep Malhotra (3)
  6. Tarun Kewalramani (3)

More People

Years
  1. 2003 (1)
  2. 2002 (2)
  3. 2001 (1)
  4. 2000 (1)
  5. 1998 (1)
Publications
  1. Blood (4)
  2. Cancer Gene Therapy (1)
  3. Proceedings of the American Association for Cancer Research Annual Meeting (1)
Publishers
  1. American Society of Hematology (4)
  2. American Association for Cancer Research (1)
  3. Nature Publishing Group (1)

Results (6)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Neoadjuvant treatment of hepatic malignancy: An oncolytic herpes simplex virus expressing IL-12 effectively treats the parent tumor and protects against recurrence-after resection
    Journal Article

    Jarnagin, W. R.; Zager, J. S.; Klimstra, D.; Delman, K. A.; Malhotra, S.; Ebright, M.; Little, S.; de Rubertis, B.; Stanziale, S. F.; Hezel, M.; more...
    Cancer Gene Therapy (2003)

    Fulltext@MSK | Save
  • Similar outcomes for chemosensitive (CS) relapsed or primary refractory peripheral T-cell lymphoma (PTCL) and diffuse large B-cell lymphoma (DLBCL) treated with autologous transplantation (ASCT)
    Meeting Abstract

    Kewalramani, T.; Nimer, S. D.; Zelenetz, A. D.; Hamlin, P. A.; Horwitz, S.; Qin, J.; Malhotra, S.; Yahalom, J.; Moskowitz, C. H.
    Blood (2002)

    Fulltext@MSK | Save
  • Autologous transplantation (ASCT) with total body irradiation (TBI) based conditioning appears superior to chemotherapy only (Non-TBI) conditioning for patients with relapsed or primary refractory chemosensitive (CS) diffuse large B-cell lymphoma (DLBCL) who have no extranodal sits (ENS) of disease (dz)
    Meeting Abstract

    Kewalramani, T.; Moskowitz, C. H.; Zelenetz, A. D.; Malhotra, S.; Qin, J.; Yahalom, J.; Nimer, S. D.
    Blood (2002)

    Fulltext@MSK | Save
  • Phase II study of accelerated fractionation involved field radiotherapy (IFRT), total body irradiation (TBI), ifosfamide and continuous infusion etoposide with autologous stem cell transplantation (ASCT) in the treatment of patients with relapsed and primary refractory aggressive non-Hodgkins lymphoma (NHL)
    Meeting Abstract

    Moskowitz, C. H.; Yahalom, J.; Zelenetz, A. D.; Kewalramani, T.; Malhotra, S.; Nimer, S. D.
    Blood (2001)

    Fulltext@MSK | Save
  • Imaging the expression of thymidine kinase (TK) to evaluate oncolytic viral therapy
    Meeting Abstract

    Bennett, J.; Malhotra, S.; Doubrovin, M.; Hackman, T.; Johnson, P.; Blasberg, R.; Tjuvajev, J.; Fong, Y.
    Proceedings of the American Association for Cancer Research Annual Meeting (2000)

    Fulltext@MSK | Save
  • Safety and efficacy of high dose therapy and peripheral blood progenitor cell transplantation (HDT/PBPCT) in patients with non-Hodgkin's lymphoma (NHL) over the age of 55 years
    Meeting Abstract

    Hedrick, E. E.; Nimer, S. D.; Zelenetz, A. D.; Childs, B.; Frank, R.; Malhotra, S.; Coady-Lyons, N.; Yahalom, J.; Moskowitz, C. H.
    Blood (1998)

    Fulltext@MSK | Save